Aging Analytics Agency has launched an interactive IT-platform alongside its “Longevity Industry in California Landscape Overview 2019” report that turns the report’s static mindmaps into dynamic and interactive infographics, enabling complex interactions between industry entities and stakeholders to be visualized, filtered, searched and thus more easily understood.
Link to IT-Platform: https://mindmaps.aginganalytics.com/longevity-industry-in-california.
Photo by Erin Ashford Yale University Principal Investigator: David Spiegel Research Team: Prof. Jason Crawford, Nam Kim, Venkata Sabbasani, Matthew Streeter The long-lived collagen proteins that give structure to our arteries and other tissues are continuously exposed to blood sugar and other highly reactive molecules necessary for life. Occasionally, …Glucosepane Crosslinks and Undoing Age-Related Tissue Damage.
May has been a great month for LEAF; there’s been a lot of exciting news, such as our president’s participation in the XPRIZE Foundation’s most recent meeting, Steve Hill making it among the top 100 journalists covering aging research, and last but not least, the launch of Lifespan.io’s brand-new, life extension-focused show, LifeXtenShow!
LEAF News
I was live on Good Morning Britain this morning talking transhumanism and life extension. It’s one of the UK’s most popular news shows. The Mirror did a write-up of the story and there’s a 2-min video embed of the interview in the article to watch:
American journalist Zoltan Istvan said that humans will be able to download many versions of themselves onto the internet.
Is aging a natural process that we simply have to accept as a fact of life?
A philosopher would say yes. Many doctors would also agree: that our cells eventually reach a point where they can no longer divide and either die or reach senescence, a retirement phase. Many scientists believe in the “Hayflick limit” — that no one can live past about 120 years old. These people might also say that aging — and dying — is a good thing; that the world is already overcrowded, that we already cannot handle our aging populations, that life must be finite to appreciate it, that all good things must come to an end.
But there’s a growing group of people — including gerontologists, biologists, engineers, and futurists—who believe that aging is a disease in itself, a disease that can be cured. That aging is not an immutable process, an inevitable “dying of the light,” to quote poet Dylan Thomas, but one we can “rage against” — through science, drugs, and lifestyle changes.
Continue reading “What’s Telling About Telomeres (and the Aging Process)” »
Ira Pastor, ideaXme longevity and aging ambassador and founder of Bioquark interviews Luba Greenwood J.D., Strategic Business Development and Corporate Ventures, Verily (Google Life Sciences), Board Member Mass Bio and Brooklyn ImmunoTherapeutics LLC.
Note: Following this interview, Verily announced a major set of collaborations with big pharma companies, further executing on its strategy in healthcare. Breaking news: https://www.cnbc.com/2019/05/20/alphabet-verily-doing-clinic…T4eLzIucEI
Continue reading “Building the Future of Global Health: Big Tech’s Big Ideas” »
Alongside our Ending Age-related Diseases 2019 annual conference, we are proud to announce the launch of a special pre-conference biotech workshop led by Dr. Kelsey Moody, CEO of Ichor Therapeutics, a successful and rapidly growing rejuvenation biotechnology company.
This joint event between the Life Extension Advocacy Foundation and Ichor Therapeutics is an essential workshop where you will learn about the fundamentals of launching and growing a successful biotechnology company with an emphasis on the nuances specific to the emerging rejuvenation biotechnology industry.
